TransMedics Group, Inc. (NASDAQ:TMDX) Receives $126.70 Consensus PT from Brokerages
Shares of TransMedics Group, Inc. (NASDAQ:TMDX – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the eleven brokerages that are presently covering the company, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has assigned a strong […]
